Browse result page of THPdb

The total number entries retrieved from this search are 53

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1361	ThPPIDTh1051	NameHuman Serum Albumin	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length609	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlbuminar	CompanyCSL Behring	Physical AppearanceSterile aqueous solution of albumin obtained from large pools of adult human venous plasma by low temperature controlled fractionation according to the Cohn process.	Route of AdministartionAlbumin (Human) 25%, Albuminar-25 (albumin human) , is to be administered by the Intravenous route.	CategorySerum substitutes	TargetN.A.
ID1362	ThPPIDTh1051	NameHuman Serum Albumin	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length609	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlbutein	CompanyGRIFOLS	Physical AppearanceSterile, aqueous solution for single dose intravenous administration containing 20% human albumin (weight/volume).	Route of AdministartionAlbutein 20% is to be administered by the Intravenous route.	CategorySerum substitutes	TargetN.A.
ID1365	ThPPIDTh1053	NameSerum albumin iodonated	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length600	Functional ClassificationIV	DiseaseHematological Disorders	BrandMegatope	CompanyIsoTex Diagnostics	Physical AppearanceColorless to very pale yellow solutions	Route of AdministartionInjection for Intravenous administration	CategoryDiagnostic Agents	TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP
ID1366	ThPPIDTh1053	NameSerum albumin iodonated	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length600	Functional ClassificationIV	DiseaseHematological Disorders	BrandJeanotope	CompanyIsoTex Diagnostics	Physical AppearanceSterile, nonpyrogenic, aqueos solution	Route of AdministartionIntravenous infusion	CategoryDiagnostic Agents	TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP
ID1367	ThPPIDTh1053	NameSerum albumin iodonated	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length600	Functional ClassificationIV	DiseaseHematological Disorders	BrandVolumex	CompanyIsoTex Diagnostics	Physical AppearanceColorless to very pale yellow.	Route of AdministartionIntravenous infusion	CategoryDiagnostic Agents	TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP
ID1381	ThPPIDTh1059	NameHyaluronidase	Peptide SequenceMWTGLGPAVTLALVLVVAWA Full view	Length476	Functional ClassificationIc	DiseaseAdjunct Therapy	BrandHYLENEX	CompanyBaxter Healthcare Corporation	Physical AppearanceSterile, clear, colorless, nonpreserved, ready for use solution.	Route of AdministartionHuman Injection Subcutaneous use	CategoryAdjuvants, Anesthesia and Permeabilizing Agents	TargetN.A.
ID1389	ThPPIDTh1062	NameRituximab	Peptide SequenceHeavy Chain: QVQLQQP Full view	Length664	Functional ClassificationIIa	DiseaseCancer/Immunological	BrandRituxan	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, clear, colorless, preservative-free liquid concentrate	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1398	ThPPIDTh1063	NameBasiliximab	Peptide SequenceHeavy Chain: QLQQSGT Full view	Length657	Functional ClassificationIIa	DiseaseImmunological	BrandSimulect	CompanyNovartis	Physical AppearanceSterile lyophilisate which is available in 6 mL colorless glass vials and is available in 10 mg and 20 mg strength	Route of Administartionintravenous infusion mainly or bolus (if no allergic reactions occurs)	CategoryImmunosuppressive Agents	TargetN.A.
ID1400	ThPPIDTh1064	NameMuromonab	Peptide SequenceHeavy Chain: QVQLQQS Full view	Length664	Functional ClassificationIIa	DiseaseImmunological	BrandORTHOCLONE OKT3 STERILE SOLUTION	CompanyCentocor Ortho Biotech, L.P.	Physical AppearanceSterile Solution is a murine monoclonal antibody to the CD3 antigen of human T cells which functions as an immunosuppressant.	Route of AdministartionFor Intravenous Use Only	CategoryImmunologic Factors and Immunosuppressive Agents	TargetN.A.
ID1403	ThPPIDTh1065	NameDigoxin Immune Fab (Ovine)	Peptide SequenceHeavy Chain: EVQLQQS Full view	Length438	Functional ClassificationIIa	DiseaseCardiac	BrandDIGIBIND	CompanyGalaxo Smith Kline	Physical AppearanceSterile lyophilized powder of antigen binding fragments (Fab) derived from specific antidigoxin antibodies raised in sheep.	Route of AdministartionIntravenous infusion after reconstitution with Sterile Water for Injection	CategoryAntidotes	TargetT-cell surface glycoprotein CD3 delta chain, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface glycoprotein CD3 gamma chain, T-cell surface glycoprotein CD3 zeta chain, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1404	ThPPIDTh1065	NameDigoxin Immune Fab (Ovine)	Peptide SequenceHeavy Chain: EVQLQQS Full view	Length438	Functional ClassificationIIa	DiseaseCardiac	BrandDigiFab	Company Protherics Inc	Physical AppearanceSterile, purified, lyophilized preparation of digoxin-immune ovine Fab (monovalent) immunoglobulin fragments.ÂÂÂ	Route of AdministartionIntravenous administrationÂÂÂ	CategoryAntidotes	TargetT-cell surface glycoprotein CD3 delta chain, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface glycoprotein CD3 gamma chain, T-cell surface glycoprotein CD3 zeta chain, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1406	ThPPIDTh1066	NameIbritumomab	Peptide SequenceHeavy Chain: QAYLQQS Full view	Length652	Functional ClassificationIIb	DiseaseCancer	BrandZevalin	CompanySpectrum Pharmaceuticals	Physical AppearanceClear, colorless, sterile, pyrogen-free, preservative-free solution that may contain translucent particles.	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetDigoxin
ID1428	ThPPIDTh1072	NameStreptokinase	Peptide SequenceMKNYLSFGMFALLFALTFGT Full view	Length440	Functional ClassificationIc	DiseaseMetabolic/Haemetological	BrandStreptase	CompanyCSL Behring	Physical AppearanceSterile, purified preparation formulated as lypholized powder	Route of AdministartionIntravenous and intracoronary administration.	CategoryFibrinolytic Agents and Thrombolytic Agents	TargetN.A.
ID1434	ThPPIDTh1074	NameAlglucerase	Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view	Length497	Functional ClassificationIa	DiseaseMetabolic	BrandCeredase	CompanyGenzyme Corporation	Physical AppearanceClear sterile non-pyrogenic solution of alglucerase in a citrate buffered solution	Route of AdministartionIntravenous injection	CategoryEnzyme Replacement Agents	TargetPlasminogen,Proteinase-activated receptor 1
ID1437	ThPPIDTh1076	NameLaronidase	Peptide SequenceAPHLVQVDAARALWPLRRFW Full view	Length626	Functional ClassificationIa	DiseaseMetabolic	BrandALDURAZYME	CompanyGenzyme Corporation	Physical AppearanceSterile, nonpyrogenic, colorless to pale yellow, clear to slightly opalescent solution that must be diluted prior to administration in 0.9% Sodium Chloride Injection	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetN.A.
ID1445	ThPPIDTh1079	NameSerum Albumin	Peptide SequenceDAHKSEVAHRFKDLGEENFK Full view	Length585	Functional ClassificationIV	DiseaseMetabolic/genetic	BrandAlbunex	CompanyMallinckrodt; Tyco Healthcare	Physical AppearanceN.A.	Route of AdministartionIntravenous infusion	CategorySerum substitutes	TargetN.A.
ID1446	ThPPIDTh1079	NameSerum Albumin	Peptide SequenceDAHKSEVAHRFKDLGEENFK Full view	Length585	Functional ClassificationIV	DiseaseMetabolic/genetic	BrandOptison	CompanyGE Healthcare	Physical AppearanceN.A.	Route of AdministartionIntravenous infusion	CategorySerum substitutes	TargetN.A.
ID1453	ThPPIDTh1083	NameCoagulation Factor Ix	Peptide SequenceYNSGKLEEFVQGNLERECME Full view	Length415	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlprolix	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, non-pyrogenic, preservative-free, white to off-white, lyophilized powder to cake for reconstitution with the provided diluent	Route of AdministartionIntravenous infusion	CategoryCoagulants and Thrombotic Agents	TargetN.A.
ID1466	ThPPIDTh1090	NameDaclizumab	Peptide SequenceQVQLVQSGAEVKKPGSSVKV Full view	Length674	Functional ClassificationIIa	DiseaseImmunologicals	BrandZenapax	CompanyRoche	Physical AppearanceClear, sterile, colorless concentrate for further dilution and intravenous administration	Route of AdministartionIntravenous injection	CategoryImmunosuppressive Agents	TargetFusion glycoprotein F0,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1475	ThPPIDTh1095	NameRanibizumab	Peptide SequenceLight Chain SASQDISN Full view	Length447	Functional ClassificationIIa	DiseaseHematological/Eye Disorder	BrandLucentis	CompanyGenentech	Physical AppearanceSterile, colorless to pale yellow solution	Route of AdministartionIntravitreal injection	CategoryOphthalmics	TargetVascular endothelial growth factor A
ID1476	ThPPIDTh1096	NameIdursulfase	Peptide SequenceSETQANSTTDALNVLLIIVD Full view	Length525	Functional ClassificationIa	DiseaseMetabolic	BrandElaprase	CompanySHIRE	Physical AppearanceSterile, nonpyrogenic clear to slightly opalescent, colorless solution that must be diluted prior to administration in 0.9% Sodium Chloride Injection, USP	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetDermatan sulfate,Heparan sulfate,Perilipin-3
ID1494	ThPPIDTh1101	NameGalsulfase	Peptide SequenceSGAGASRPPHLVFLLADDLG Full view	Length497	Functional ClassificationIa	DiseaseMetabolic	BrandNaglazyme	CompanyBioMarin	Physical AppearanceSterile, nonpyrogenic, colorless to pale yellow, clear to slightly opalescent solution that must be diluted with 0.9% Sodium Chloride Injection, USP, prior to administration	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetDermatan sulfate,Perilipin-3
ID1548	ThPPIDTh1117	NameIpilimumab	Peptide SequenceHeavy chain: QVQLVES Full view	Length663	Functional ClassificationIIIc	DiseaseCancer	BrandYERVOY	CompanyBristol-Myers Squibb	Physical AppearanceSterile, preservative-free, clear to slightly opalescent, colorless to pale-yellow solution	Route of AdministartionN.A.	CategoryAntineoplastic Agents and Monoclonal antibodies	TargetCytotoxic T-lymphocyte protein 4
ID1560	ThPPIDTh1121	NamePertuzumab	Peptide Sequencelight chain DIQMTQSP Full view	Length664	Functional ClassificationIIIc	DiseaseCancer	BrandPerjeta	CompanyGenentech	Physical AppearanceSterile, clear to slightly opalescent, colorless to pale brown liquid	Route of AdministartionIntravenous infusion	CategoryMonoclonal antibodies	TargetReceptor tyrosine-protein kinase erbB-2
ID1570	ThPPIDTh1123	NameDenosumab	Peptide SequenceHeavy chain EVQLLESG Full view	Length664	Functional ClassificationIIIc	DiseaseOsteological	BrandXgeva	CompanyAmgen.	Physical AppearanceSterile, preservative-free, clear, colorless to pale yellow solution	Route of AdministartionN.A.	CategoryBone Density Conservation Agents and Monoclonal antibodies	TargetTumor necrosis factor ligand superfamily member 11
ID1571	ThPPIDTh1123	NameDenosumab	Peptide SequenceHeavy chain EVQLLESG Full view	Length664	Functional ClassificationIIIc	DiseaseOsteological	BrandProlia	CompanyAmgen.	Physical AppearanceSterile, preservative-free, clear, colorless to pale yellow solution	Route of AdministartionN.A.	CategoryBone Density Conservation Agents and Monoclonal antibodies	TargetTumor necrosis factor ligand superfamily member 11
ID1602	ThPPIDTh1128	NameVelaglucerase Alfa	Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view	Length497	Functional ClassificationIa	DiseaseHormonal	BrandVPRIV	CompanyShire	Physical AppearanceSterile, preservative free, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryEnzymes	TargetGlucosylceramidase
ID1604	ThPPIDTh1130	NameBrentuximab Vedotin	Peptide SequenceHeavy chain:QIQLQQSG Full view	Length664	Functional ClassificationIIb	DiseaseCancer	BrandAdcetris	CompanySeattle Genetics	Physical AppearanceSterile, white to off-white, preservative-free lyophilized cake or powder in single-use vials.	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetTumor necrosis factor receptor superfamily member 8
ID1608	ThPPIDTh1131	NameTaliglucerase Alfa	Peptide SequenceEFARPCIPKSFGYSSVVCVC Full view	Length504	Functional ClassificationIa	DiseaseHormonal	BrandElelyso	CompanyPfizer	Physical AppearanceSterile, non-pyrogenic, lyophilized product.	Route of AdministartionIntravenous infusion	CategoryEnzymes	TargetGlucocerebroside
ID1615	ThPPIDTh1133	NameAflibercept	Peptide SequenceSDTGRPFVEMYSEIPEIIHM Full view	Length431	Functional ClassificationIb	DiseaseCancer	BrandEylea	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, clear, and colorless to pale yellow solution.	Route of AdministartionIntravitreal injection	CategoryAntineoplastic Agents and Ophthalmics	TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1616	ThPPIDTh1133	NameAflibercept	Peptide SequenceSDTGRPFVEMYSEIPEIIHM Full view	Length431	Functional ClassificationIb	DiseaseCancer	BrandZaltrap	CompanySanofi and Regeneron Pharmaceuticals, Inc.	Physical AppearanceSterile, clear, colorless to pale yellow, non-pyrogenic, preservative-free, solution.	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents and Ophthalmics	TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1628	ThPPIDTh1139	NameCertolizumab Pegol	Peptide SequenceLight chain: DIQMTQS Full view	Length443	Functional ClassificationIIb	DiseaseImmunologcal	BrandCimzia	CompanyUCB	Physical AppearanceSterile, white, lyophilized powder for solution or as a sterile, solution in a single-use prefilled 1 mL glass syringe	Route of AdministartionSubcutaneous injection	CategoryTNF inhibitor	TargetTumor necrosis factor
ID1637	ThPPIDTh1143	NameFibrinolysin Aka Plasmin	Peptide SequenceFibrinolysin heavy c Full view	Length786	Functional ClassificationIc	DiseaseHematological	BrandElase	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryN.A.	TargetN.A.
ID1654	ThPPIDTh1150	NameSecukinumab	Peptide SequenceSecukinumab Heavy Ch Full view	Length672	Functional ClassificationIIa	DiseaseImmunological	BrandCosentyx	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceSterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution.	Route of AdministartionSubcutaneous injection	CategoryInhibitor	TargetIL-17A cytokine
ID1659	ThPPIDTh1152	NameDrotrecogin alfa	Peptide SequenceHeavy Chain: LIDGKMT Full view	Length402	Functional ClassificationIb	DiseaseInfectious	BrandXigris	CompanyEli Lilly and Company	Physical AppearanceSterile, lyophilized, white to off-white powder	Route of AdministartionIntravenous Infusion	CategoryAntisepsis	TargetCoagulation factor VIII, V, Plasminogen activator inhibitor 1, Thrombomodulin, Vitamin K-dependent protein S, Ceruloplasmin, Prothrombin, Platelet factor 4, Plasma serine protease inhibitor, Serpin B6, Vitamin K-dependent gamma-carboxylase, Endothelial protein C receptor
ID1661	ThPPIDTh1153	NameAlefacept	Peptide SequenceHeavy Chain: CFSQQIY Full view	Length705	Functional ClassificationIIa	DiseaseImmunological	BrandAmevive	CompanyAstellas Pharma Inc.	Physical AppearanceSterile, white-to-off-white, preservative-free, lyophilized powder	Route of AdministartionIntramuscular Injection	CategoryDermatologic and Immunosupressive agents	TargetT-cell surface antigen CD2, Complement C1r subcomponent, Complement C1q subcomponent subunit A, B, C, Low affinity immunoglobulin gamma Fc region receptor III-A,III-B, II-a, II-b, II-c
ID1671	ThPPIDTh1159	NameGemtuzumab ozogamicin	Peptide SequenceLight Chain 1: QIVLT Full view	Length459	Functional ClassificationIIb	DiseaseCancer	BrandMylotarg	CompanyWyeth pharmaceuticals inc	Physical AppearanceSterile, white, preservative-free lyophilized powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic agents and Immunotoxins	TargetMyeloid cell surface antigen CD33, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1674	ThPPIDTh1161	NameAlbiglutide	Peptide SequenceHGEGTFTSDVSSYLEGQAAK Full view	Length645	Functional ClassificationIb	DiseaseHormonal disorders	BrandEperzan	CompanyGlaxosmithkline Inc	Physical AppearancePowder for Solution	Route of AdministartionSubcutaneous	CategoryDrugs used in diabetes; alimentary tract and metabolism; blood glucose lowering drugs, excl. insulins.	TargetGlucagon-like peptide 1 receptor
ID1676	ThPPIDTh1161	NameAlbiglutide	Peptide SequenceHGEGTFTSDVSSYLEGQAAK Full view	Length645	Functional ClassificationIb	DiseaseHormonal disorders	BrandTanzeum	CompanyGlaxo Smith Kline Llc	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionSubcutaneous	CategoryDrugs used in diabetes; alimentary tract and metabolism; blood glucose lowering drugs, excl. insulins.	TargetGlucagon-like peptide 1 receptor
ID1694	ThPPIDTh1166	NameAsfotase Alfa	Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view	Length726	Functional ClassificationIa	DiseaseGenetic Disorders	BrandStrensiq	CompanyAlexion Pharma Ghbh	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryEnzymes Alimentary Tract and Metabolism	TargetSphingosine 1-phosphate receptor 1; Pyrophosphate
ID1695	ThPPIDTh1166	NameAsfotase Alfa	Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view	Length726	Functional ClassificationIa	DiseaseGenetic Disorders	BrandStrensiq	CompanyAlexion Pharmaceuticals Inc.	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryEnzymes Alimentary Tract and Metabolism	TargetSphingosine 1-phosphate receptor 1; Pyrophosphate
ID1708	ThPPIDTh1170	NameBlinatumomab	Peptide SequenceDIQLTQSPASLAVSLGQRAT Full view	Length504	Functional ClassificationIIIc	DiseaseCancer/Genetic	BrandBlincyto	CompanyAMGEN	Physical AppearanceLyophilized Powder for intravenous administration	Route of AdministartionIntravenous	CategoryAntineoplastic Agents, Immunosuppressive Agents, Monoclonal antibodies, Antineoplastic and Immunomodulating Agents	TargetB-lymphocyte antigen CD19; T-cell surface glycoprotein CD3 delta chain
ID1736	ThPPIDTh1177	NameElosulfase alfa	Peptide SequenceAPQPPNILLLLMDDMGWGDL Full view	Length496	Functional ClassificationIa	DiseaseMetabolic Disorders	BrandVimizim	CompanyBiomarin International Limited	Physical AppearanceSolution	Route of AdministartionIntravenous	CategoryEnzymes; Alimentary Tract and Metabolism	TargetN-acetylgalactosamine-6-sulfatase
ID1738	ThPPIDTh1178	NameElotuzumab	Peptide Sequenceheavy chain EVQLVESG Full view	Length689	Functional ClassificationIIIc	DiseaseCancer	BrandNA	CompanyNA	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionIntravenous	CategoryNA	TargetSLAM family member 7
ID1739	ThPPIDTh1178	NameElotuzumab	Peptide Sequenceheavy chain EVQLVESG Full view	Length689	Functional ClassificationIIIc	DiseaseCancer	BrandEmpliciti	CompanyE.R. Squibb & Sons, L.L.C.	Physical AppearancePowder Lyophilized for Solution	Route of AdministartionIntravenous	CategoryNA	TargetSLAM family member 8
ID1740	ThPPIDTh1178	NameElotuzumab	Peptide Sequenceheavy chain EVQLVESG Full view	Length689	Functional ClassificationIIIc	DiseaseCancer	BrandEmpliciti	CompanyE.R. Squibb & Sons, L.L.C.	Physical AppearancePowder Lyophilized for Solution	Route of AdministartionIntravenous	CategoryNA	TargetSLAM family member 9
ID1797	ThPPIDTh1191	NameVedolizumab	Peptide SequenceHeavy Chain Sequence Full view	Length716	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandEntyvio	CompanyTakeda Pharmaceuticals America, Inc.	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionIntravenous	CategoryImmunosupressive agent, Antineoplastic agent	TargetIntegrin alpha-4, Integrin beta-7
ID1802	ThPPIDTh1196	NameSiltuximab	Peptide SequenceHeavy Chain Sequence Full view	Length708	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandSylvant	CompanyJanssen Inc	Physical AppearanceLyophilized Powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic and Immunomodulating Agents, Immunosuppressive Agents	TargetInterleukin-6
ID1811	ThPPIDTh1202	NamePembrolizumab	Peptide SequenceHeavy Chain Sequence Full view	Length711	Functional ClassificationIIIc	DiseaseCancer	BrandKeytruda	CompanyMerck Sharp & Dohme Corp.	Physical AppearanceLyophilized Powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic and Immunomodulating Agents	TargetProgrammed cell death protein 1
ID1813	ThPPIDTh1204	NameOfatumumab	Peptide SequenceOfatumumab Heavy Cha Full view	Length483	Functional ClassificationIIIc	DiseaseCancer	BrandArzerra	CompanyGlaxo Smith Kline Llc	Physical AppearanceLiquid	Route of AdministartionIntravenous	CategoryAntineoplastic and Immunomodulating Agents	Target